// News

July 19, 2018: In The Know

Tags: , , , , , , , , , , , , , , , ,

Implantable Organ Developer Miromatrix Medical Raises $15.7M

Minnesota health tech company accepted to world’s largest tech incubator, Station F in Paris

Relievant Announces First Commercial Intracept Procedures

 

Abbott Receives FDA Approval for Next-Generation MitraClip® Device To Treat People With Leaky Heart Valves

Inspire Medical CEO on going public, ramping up growth and ringing the stock-exchange bell

Vyriad Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Oncolytic Virus, Voyager-V1, in Combination with Anti-PD-L1 Antibody, Avelumab, in Phase 1 Clinical Study for Metastatic Colorectal Cancer

Netherlands-based Haga Teaching Hospital partners with physIQ and VitalConnect to continuously monitor cancer patients during treatment

Bright Health to expand its Obamacare footprint in 9 new markets

Why convergence is part of the future of healthcare

Bio-Techne Scales Antibody Validation Initiative Using CRISPR Gene Editing Technology Across a Broad Spectrum of Targets

Trio of Minnesota Stem Cell Startups Receive State-Funded Commercialization Grants

CHF Solutions enters the German marketplace

Medibio Submits FDA De Novo Application

Pelican BioThermal Announces Availability of its New CoolPall™ Flex Bulk Shipper System

How the Didgeridoo and Physical Therapy Inspired a Local Sleep Startup

Med Tech Company Launches Clothing Line That Protects The Skin Of “Butterfly” Children 

Humanetics Awarded Patent for Oral Drug to Protect Warfighters and First Responders from Radiation Exposure

Zipnosis Earns Surescripts® Certification to Strengthen Physician Workflows and Enhance Physician Experience

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER